These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 19003969)
1. Dkk3, downregulated in cervical cancer, functions as a negative regulator of beta-catenin. Lee EJ; Jo M; Rho SB; Park K; Yoo YN; Park J; Chae M; Zhang W; Lee JH Int J Cancer; 2009 Jan; 124(2):287-97. PubMed ID: 19003969 [TBL] [Abstract][Full Text] [Related]
2. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours. Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564 [TBL] [Abstract][Full Text] [Related]
3. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo. Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic silencing of the WNT antagonist Dickkopf 3 disrupts normal Wnt/β-catenin signalling and apoptosis regulation in breast cancer cells. Xiang T; Li L; Yin X; Zhong L; Peng W; Qiu Z; Ren G; Tao Q J Cell Mol Med; 2013 Oct; 17(10):1236-46. PubMed ID: 23890219 [TBL] [Abstract][Full Text] [Related]
5. SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway. Chung MT; Lai HC; Sytwu HK; Yan MD; Shih YL; Chang CC; Yu MH; Liu HS; Chu DW; Lin YW Gynecol Oncol; 2009 Mar; 112(3):646-53. PubMed ID: 19095296 [TBL] [Abstract][Full Text] [Related]
6. Dickkopf3 overexpression inhibits pancreatic cancer cell growth in vitro. Gu YM; Ma YH; Zhao WG; Chen J World J Gastroenterol; 2011 Sep; 17(33):3810-7. PubMed ID: 21987623 [TBL] [Abstract][Full Text] [Related]
7. Reduced expression of DKK3 is associated with adverse clinical outcomes of uterine cervical squamous cell carcinoma. Ryu SW; Kim JH; Kim MK; Lee YJ; Park JS; Park HM; Kim DH; Lee SH; Lee EJ Int J Gynecol Cancer; 2013 Jan; 23(1):134-40. PubMed ID: 23154266 [TBL] [Abstract][Full Text] [Related]
8. SOX17 restrains proliferation and tumor formation by down-regulating activity of the Wnt/β-catenin signaling pathway via trans-suppressing β-catenin in cervical cancer. Li L; Yang WT; Zheng PS; Liu XF Cell Death Dis; 2018 Jul; 9(7):741. PubMed ID: 29970906 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of Dkk3 activates beta-catenin/TCF-4 signaling in lung cancer. Yue W; Sun Q; Dacic S; Landreneau RJ; Siegfried JM; Yu J; Zhang L Carcinogenesis; 2008 Jan; 29(1):84-92. PubMed ID: 18048388 [TBL] [Abstract][Full Text] [Related]
10. DKK3 blocked translocation of β-catenin/EMT induced by hypoxia and improved gemcitabine therapeutic effect in pancreatic cancer Bxpc-3 cell. Guo Q; Qin W J Cell Mol Med; 2015 Dec; 19(12):2832-41. PubMed ID: 26395974 [TBL] [Abstract][Full Text] [Related]
11. Dickkopf-3 expression is a marker for neuroblastic tumor maturation and is down-regulated by MYCN. Koppen A; Ait-Aissa R; Koster J; Øra I; Bras J; van Sluis PG; Caron H; Versteeg R; Valentijn LJ Int J Cancer; 2008 Apr; 122(7):1455-64. PubMed ID: 18059033 [TBL] [Abstract][Full Text] [Related]
12. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling. Shin H; Kim JH; Lee YS; Lee YC Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic effects of antibiotic drug tigecycline against cervical squamous cell carcinoma by inhibiting Wnt/β-catenin signaling. Li H; Jiao S; Li X; Banu H; Hamal S; Wang X Biochem Biophys Res Commun; 2015 Nov; 467(1):14-20. PubMed ID: 26427870 [TBL] [Abstract][Full Text] [Related]
14. MYCN is a novel oncogenic target in adult B-ALL that activates the Wnt/β-catenin pathway by suppressing DKK3. Kong D; Zhao L; Sun L; Fan S; Li H; Zhao Y; Guo Z; Lin L; Cui L; Wang K; Chen W; Zhang Y; Zhou J; Li Y J Cell Mol Med; 2018 Jul; 22(7):3627-3637. PubMed ID: 29673070 [TBL] [Abstract][Full Text] [Related]
15. Expression of the Wnt antagonist Dickkopf-3 is associated with prognostic clinicopathologic characteristics and impairs proliferation and invasion in endometrial cancer. Dellinger TH; Planutis K; Jandial DD; Eskander RN; Martinez ME; Zi X; Monk BJ; Holcombe RF Gynecol Oncol; 2012 Aug; 126(2):259-67. PubMed ID: 22555103 [TBL] [Abstract][Full Text] [Related]
16. Protein arginine methyltransferase 5 (PRMT5) activates WNT/β-catenin signalling in breast cancer cells via epigenetic silencing of DKK1 and DKK3. Shailesh H; Siveen KS; Sif S J Cell Mol Med; 2021 Feb; 25(3):1583-1600. PubMed ID: 33462997 [TBL] [Abstract][Full Text] [Related]
17. HCV Core protein represses DKK3 expression via epigenetic silencing and activates the Wnt/β-catenin signaling pathway during the progression of HCC. Wang X; Zhou Y; Wang C; Zhao Y; Cheng Y; Yu S; Li X; Zhang W; Zhang Y; Quan H Clin Transl Oncol; 2022 Oct; 24(10):1998-2009. PubMed ID: 35768685 [TBL] [Abstract][Full Text] [Related]
18. A novel FOXO1-mediated dedifferentiation blocking role for DKK3 in adrenocortical carcinogenesis. Cheng JY; Brown TC; Murtha TD; Stenman A; Juhlin CC; Larsson C; Healy JM; Prasad ML; Knoefel WT; Krieg A; Scholl UI; Korah R; Carling T BMC Cancer; 2017 Mar; 17(1):164. PubMed ID: 28249601 [TBL] [Abstract][Full Text] [Related]
19. Hydralazine inhibits human cervical cancer cell growth in vitro in association with APC demethylation and re-expression. Song Y; Zhang C Cancer Chemother Pharmacol; 2009 Mar; 63(4):605-13. PubMed ID: 18521605 [TBL] [Abstract][Full Text] [Related]
20. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway. Shan BE; Wang MX; Li RQ Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]